In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Hafslund Nycomed and Ivax to merge via stock swap

Executive Summary

To stay market leaders in their respective niches Ivax (generics) and Hafslund Nycomed (imaging agents) will merge in a 1:1 stock swap valued at $2.5 billion that will give both companies a global scale in R&D and marketing.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies